AzTrials
AzTrials

Response RateNCT03046368

Personalization of Cover Letter and Response Rate

A study testing Targeted cover letter in people with Response Rate, run by University of Southern Denmark at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Several studies indicate that a survey that adapts personalized design features achieves higher participation rates. A feature can be a personalized cover letter which appears more relevant and interesting for the sample member. Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Response Rate
What is being tested?
Targeted cover letter
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25,000 participants
Where
1 siteDenmark
Study dates
3 Feb 2017to 1 Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • individuals (including institutionalized individuals) aged 16 years or older and resident in Denmark per 1 January 2017.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • National Institute of Public health, University of Southern Denmark

    Copenhagen, 1353

Other trials in Denmark

About this study

Official title: Personalization of Cover Letter and Response Rate - a Randomized Controlled Trial in the Danish Health and Morbidity Survey

Several studies indicate that a survey that adapts personalized design features achieves higher participation rates. A feature can be a personalized cover letter which appears more relevant and interesting for the sample member. In the spirit of adaptive design, this study seeks to establish whether it can be advantageous for participation overall to use cover letters with targeted content and whether the effect on participation of different versions of the cover letter varies in sample subgroups in order to optimize design features in future surveys.

Read the detailed description

Background and aim: In the Danish Health and Morbidity Surveys the participation rate has declined from 61% in 2010 to 57% in 2013. A declining participation rate may affect the representativeness and the results of the survey. Several studies indicate that a survey that adapts personalized design features achieves higher participation rates. A feature can be a personalized cover letter which appears more relevant and interesting for the sample member. The research question, then, is whether cover letters with targeted content can perform better than a standard letter. The proposition is that such letters should increase the willingness of some sample members to participate, and that this will be reflected in higher response rates. However, little is known about which targeted content is the most effective.

Thus, in the spirit of adaptive design, this study seeks to establish whether it can be advantageous for participation overall to use cover letters with targeted content and whether the effect on participation of different versions of the cover letter varies in sample subgroups in order to optimize design features in future surveys. Further, given that the majority of sample members participate, these sample members who are swayed by the targeted letter must have relatively low response propensities (with the standard letter). Thus, we hypothesize that targeted letters should particularly improve response rates in low response propensity subgroups (i.e. young men, unmarried, and elderly women). A secondary research question is, therefore, whether any effect of targeted letters on response rate is greater among sample subgroups with low response propensities.

Design: A randomized trial will be incorporated the Danish Health and Morbidity Survey 2017 where a paragraph in the cover letter intended to heighten perceptions of relevance of the survey is varied among sample members. The Danish Health and Morbidity Survey 2017 will be based on a nationally representative random sample of 25,000 individuals (including institutionalized individuals) aged 16 years or older and resident in Denmark per 1 January 2017. The sample will be drawn from the adult population in Denmark using the Danish Civil Registration System and the survey will be conducted between February 3 and Maj 5, 2017. All sample members will be randomly allocated, with equal probabilities, to one of 11 treatment groups. One group will receive a standard letter that is designed to have general appeal and the other 10 groups will receive one of 10 versions of the targeted cover letter. In the previous Health and Morbidity Surveys, all sample members received the same standard letter. Much of the content of the standard letter and the targeted letter will be the same. The intention is to hold constant features designed to demonstrate the credibility of the survey, to allay fears about confidentiality, to appeal to self-interest, and to provide basic information about the task of participation. All sample members will be invited either to complete a web questionnaire or to fill out a paper questionnaire concerning health and morbidity.

Statistics: The analysis will be based on logistic regression modelling of the 25,000 persons invited to the Health and Morbidity Survey 2017. The independent variable is a dichotomous indicator of treatment group: targeted or standard letter. The dependent variable indicates whether the sample member has fully or partially completed the questionnaire. The mediator variable indicates membership of each of three operationally important low response propensity groups (i.e. young men, unmarried, and elderly women). The approach is to first test for a main effect of the independent variable in each of the treatment groups. A second step is to conduct the same analysis stratified by treatment group. A third step will then seek to identify whether any significant effects occurs between the mediator variable and dependent variable.

Conditions
Response Rate
Being tested
Targeted cover letter

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Targeted cover letterBehavioural

    The intervention Group will receive a cover letter with targeted content with the purpose of increasing participation

Study groups in NCT03046368
Study groupRoleWhat they receive
Standard cover letterNo interventionThe group will receive a standard cover letter to the survey that is designed to have broad appeal: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark.
Targeted cover letter 1ExperimentalThis group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, alcohol and sleep problems.
Receives: Behavioral: Targeted cover letter
Targeted cover letter 2ExperimentalThis group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, alcohol and contact to family and friends.
Receives: Behavioral: Targeted cover letter
Targeted cover letter 3ExperimentalThis group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, alcohol and sex
Receives: Behavioral: Targeted cover letter
Targeted cover letter 4ExperimentalThis group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, sleep problems and contact to family and friends.
Receives: Behavioral: Targeted cover letter
Targeted cover letter 5ExperimentalThis group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, sleep problems and sex.
Receives: Behavioral: Targeted cover letter
Targeted cover letter 6ExperimentalThis group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as stress, sex and contact to family and friends.
Receives: Behavioral: Targeted cover letter
Targeted cover letter 7ExperimentalThis group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as sex, sleep problems and contact to family and friends.
Receives: Behavioral: Targeted cover letter
Targeted cover letter 8ExperimentalThis group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as sex, sleep problems and alcohol.
Receives: Behavioral: Targeted cover letter
Targeted cover letter 9ExperimentalThis group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as sex, alcohol and contact to family and friends.
Receives: Behavioral: Targeted cover letter
Targeted cover letter 10ExperimentalThis group will receive a cover letter to the survey including the paragraph: You have been randomly selected to participate in a survey of well-being, health and disease among adolescents and adults in Denmark. The questionnaire will address themes such as alcohol, sleep problem and contact to family and friends.
Receives: Behavioral: Targeted cover letter

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall response rate

    Response rate overall and in the different intervention arms

    Measured: Up to 3 months (from February 3 2017 to maxium Maj 5 2017)

Secondary outcomes (1)
  1. Response rate in different subgroups

    Response rate in different subgroups with low response propensity

    Measured: Up to 3 months (from February 3 2017 to maxium Maj 5 2017)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2017 (estimated)
  2. Study start3 Feb 2017
  3. Primary completion19 May 2017
  4. Study completion1 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
25,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03046368
Sponsor's protocol ID
60110-5060-FL
Status last verified
Mar 2020
First submitted
2 Feb 2017
Last updated
24 Mar 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Christensen AI, Lynn P, Tolstrup JS. Can targeted cover letters improve participation in health surveys? Results from a randomized controlled trial. BMC Med Res Methodol. 2019 Jul 17;19(1):151. doi: 10.1186/s12874-019-0799-4.

    PubMed 31315577

Questions about this trial

What is this clinical trial studying?

A study testing Targeted cover letter in people with Response Rate, run by University of Southern Denmark at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall response rate (time frame: Up to 3 months (from February 3 2017 to maxium Maj 5 2017)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03046368, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in